US2008293673A1PendingUtilityA1

N-acetyglucosamine derivatives and use thereof

Assignee: KAO CORPPriority: Oct 9, 2002Filed: Apr 23, 2008Published: Nov 27, 2008
Est. expiryOct 9, 2022(expired)· nominal 20-yr term from priority
A61P 43/00C07H 15/04A61K 8/60C07H 13/06A61Q 19/00A61Q 17/04A61P 17/00A61Q 19/08A61Q 19/10A61P 17/16C07H 5/06A61K 31/7008C07H 5/04
51
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to An N-acetylglucosamine derivative represented by the following formula (1), and a hyaluronic acid production promoting agent containing the same and a skin external preparation containing the same: wherein R 1 is a hydrogen atom or an alkyl group having 2 to 18 carbon atoms; R 2 , R 3 , and R 4 are hydrogen atoms or acyl groups having 2 to 18 carbon atoms and may be all the same or different from others; the steric structure at position 1 may be α or β; provided that R 1 , R 2 , R 3 , and R 4 must not be all hydrogen atoms. It is intended to provide an easily available hyaluronic acid production promoting agent and a skin external preparation whereby the production of hyaluronic acid can be promoted in the skin and thus the skin can be maintained in a vital and moist state so that it is expected that the human skin can be prevented from age.

Claims

exact text as granted — not AI-modified
1 . A method for promoting hyaluronic acid production in skin, comprising applying to the skin a composition comprising an N-acetylglucosamine derivative of formula (1): 
     
       
         
         
             
             
         
       
       wherein R 1  is a hydrogen atom or an alkyl group having 2 to 18 carbon atoms; R 2 , R 3 , and R 4  are hydrogen atoms or acyl groups having 2 to 18 carbon atoms and may be all the same or different from others; the steric structure at position 1 may be α or β; provided that R 1 , R 2 , R 3 , and R 4  must not be all hydrogen atoms. 
     
   
   
       2 . The method of  claim 1 , wherein the N-acetylglucosamine derivative of the formula (1) is an N-acetylglucosamine derivative of formula (2) or (3): 
     
       
         
         
             
             
         
       
       wherein R 5  is an alkyl group having 2 to 18 carbon atoms; R 6  is a hydrogen atom or an acetyl group; and the steric structure at position 1 may be α or β; or 
     
     
       
         
         
             
             
         
       
       wherein R 7  is a hydrogen atom or an alkyl group having 2 to 18 carbon atoms; R 8  is an acyl group having 2 to 18 carbon atoms; and the steric structure at position 1 may be α or β. 
     
   
   
       3 . The method of  claim 1 , wherein the N-acetylglucosamine derivative of the formula (1) is an N-acetylglucosamine derivative of formula (4): 
     
       
         
         
             
             
         
       
       wherein the steric structure at position 1 may be α or β. 
     
   
   
       4 . The method of  claim 1 , wherein the N-acetylglucosamine derivative of the formula (1) is an N-acetylglucosamine derivative of formula (5): 
     
       
         
         
             
             
         
       
       wherein the steric structure at position 1 may be α or β. 
     
   
   
       5 . The method of  claim 1 , wherein the N-acetylglucosamine derivative of the formula (1) is an N-acetylglucosamine derivative of formula (6): 
     
       
         
         
             
             
         
       
       wherein the steric structure at position 1 may be α or β. 
     
   
   
       6 . The method of  claim 1 , wherein the N-acetylglucosamine derivative of the formula (1) is an N-acetylglucosamine derivative of formula (7): 
     
       
         
         
             
             
         
       
       wherein the steric structure at position 1 may be α or β. 
     
   
   
       7 . The method of  claim 1 , wherein the N-acetylglucosamine derivative of the formula (1) is an N-acetylglucosamine derivative of formula (8): 
     
       
         
         
             
             
         
       
       wherein the steric structure at position 1 may be α or β. 
     
   
   
       8 . The method of  claim 1 , wherein the N-acetylglucosamine derivative of the formula (1) is an N-acetylglucosamine derivative of formula (9): 
     
       
         
         
             
             
         
       
       wherein the steric structure at position 1 may be α or β. 
     
   
   
       9 . The method of  claim 1 , wherein the N-acetylglucosamine derivative of the formula (1) is an N-acetylglucosamine derivative of formula (10): 
     
       
         
         
             
             
         
       
       wherein the steric structure at position 1 may be α or β. 
     
   
   
       10 . A method for promoting hyaluronic acid production in skin, comprising applying to the skin a composition comprising an N-acetylglucosamine derivative of formula (11): 
     
       
         
         
             
             
         
       
       wherein the steric structure at position 1 may be α or β. 
     
   
   
       11 . The method of  claim 1 , wherein the N-acetylglucosamine derivative of the formula (1) is an N-acetylglucosamine derivative of formula (12): 
     
       
         
         
             
             
         
       
       wherein the steric structure at position 1 may be α or β. 
     
   
   
       12 . The method of  claim 1 , wherein the N-acetylglucosamine derivative of the formula (1) is an N-acetylglucosamine derivative of formula (13): 
     
       
         
         
             
             
         
       
       wherein the steric structure at position 1 may be α or β. 
     
   
   
       13 . The method of  claim 1 , wherein the N-acetylglucosamine derivative of the formula (1) is an N-acetylglucosamine derivative of formula (14): 
     
       
         
         
             
             
         
       
       wherein the steric structure at position 1 may be α or β. 
     
   
   
       14 . A method for promoting hyaluronic acid production in skin, comprising applying to the skin a composition comprising is an N-acetylglucosamine derivative of formula (15): 
     
       
         
         
             
             
         
       
       wherein the steric structure at position 1 may be α or β. 
     
   
   
       15 . A method for promoting hyaluronic acid production in skin, comprising applying to the skin a composition comprising an N-acetylglucosamine derivative of formula (16): 
     
       
         
         
             
             
         
       
       wherein R 9  is an acyl group having 2 to 16 carbon atoms and the steric structure at position 1 may be α or β. 
     
   
   
       16 . The method of  claim 15 , wherein the N-acetylglucosamine derivative of the formula (16) is an N-acetylglucosamine derivative of formula (17): 
     
       
         
         
             
             
         
       
       wherein the steric structure at position 1 may be α or β. 
     
   
   
       17 . The method of  claim 1 , wherein the method is for retaining vital, elastic, and moist skin. 
   
   
       18 . The method of  claim 10 , wherein the method is for retaining vital, elastic, and moist skin. 
   
   
       19 . The method of  claim 14 , wherein the method is for retaining vital, elastic, and moist skin. 
   
   
       20 . The method of  claim 15 , wherein the method is for retaining vital, elastic, and moist skin.

Join the waitlist — get patent alerts

Track US2008293673A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.